Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • frymor
    Senior Member
    • May 2010
    • 151

    fastq_screen vs. tophat2

    Hi all,

    I was wondering about why I get a relatively low percentage of reads mapped to my genome.
    We are running an experiment of several fruit fly samples. we have several time-points and knock-outs.
    the fastq files are around 100M reads, but unfortunately I am able to map between 65-75% of them.

    To check for contamination I have tried the tools fastQ_screen. Apparently my data set is good (s. image).

    The quality of the data is very good and the according to my fastqc results, I don't have any noteworthy duplications in the data.
    What I don't understand is how bowtie2 in the fastq_screen can assign >98% of the reads to the fly genome, but in tophat2 run I get only ~65%.

    These are the command I have used to run both tophat2 and fastq_screen:
    Code:
    tophat -p 10 -G genes.gtf -o A ~/genomes/Drosophila_melanogaster/Ensembl/BDGP6.80/bowtie2index/genome 28023_TGACCA_C7F7GANXX_5_20150619B_20150619.fastq
    and
    Code:
    ./fastq_screen --force --nohits --subset 0 --outdir B --aligner bowtie2 --threads 14 28025_CGATGT_C7F7GANXX_8_20150619B_20150619.fastq
    Does bowtie2 uses different parameters in fastq_screen than in the tophat2 run?
    Is there a way to increase the mapping results?

    thanks for any ideas or hints,
    Assa


  • Brian Bushnell
    Super Moderator
    • Jan 2014
    • 2709

    #2
    Tophat is not very sensitive by default. You could have low-quality data, or adapter contamination; in either case, those reads would generally not map. I suggest you try adapter-trimming and quality-trimming, to see if that improves things.

    You can also dramatically increase the sensitivity by using BBMap instead of TopHat. For RNA-seq in animals, I suggest adding the flag "maxindel=200k"; otherwise, the defaults are fine:
    bbmap.sh in=reads.fq out=mapped.sam ref=fly.fa maxindel=200k

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 07-20-2026, 11:10 AM
    0 responses
    20 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-13-2026, 10:26 AM
    0 responses
    33 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-09-2026, 10:04 AM
    0 responses
    44 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-08-2026, 10:08 AM
    0 responses
    30 views
    0 reactions
    Last Post SEQadmin2  
    Working...